CDT Equity Inc. CEO Change; Stockholders Approve Reverse Split Authority

What Happened

• CDT Equity Inc. announced on August 31, 2026 that James Bligh was appointed Chief Executive Officer effective immediately. Mr. Bligh will continue to serve on the Board and remain Chief Financial Officer until a successor CFO is named.
• On the same date, Dr. Andrew Regan resigned as CEO and from the Board, effective immediately; the Board size was reduced from five to four following his departure. The company said Dr. Regan’s resignation was not due to any disagreement with the company.
• At the August 28, 2026 annual meeting, stockholders re-elected the company’s director nominees, ratified the independent auditor, approved authority for a reverse stock split (board may choose any whole-number ratio from 1-for-2 up to 1-for-100, aggregate not to exceed 1-for-500), and approved certain equity issuances under Nasdaq rules.

Key Details

• James Bligh compensation: $600,000 annual base salary; eligible for annual cash performance bonus with a 50% target of base salary; will receive standard senior officer benefits and expense reimbursement.
• Employment terms: either party may terminate with 12 months’ written notice; company may terminate immediately with a payment in lieu equal to base salary for the unexpired notice period, or immediately for Cause without payment. Agreement governed by Cayman Islands law.
• Andrew Regan severance: $50,000 per month for six months following resignation.
• Annual meeting vote highlights:
  • Directors re-elected (example counts): Andrew Regan — For 297,254; Withheld 14,911 (he was re-elected at the meeting and resigned effective Aug 31).
  • Auditor ratification (Carr, Riggs & Ingram): For 302,336; Against 8,643; Abstain 1,186.
  • Reverse split authority: For 240,831; Against 36,330; Abstain 35,004.
  • Approvals for issuance of shares/warrants under Nasdaq rules carried with majority votes (see filing for full counts).

Why It Matters

• Leadership change: Appointing Mr. Bligh as CEO (while he remains CFO and a director) signals continuity of management but concentrates executive responsibilities in one person until a successor CFO is named. Investors should note potential operational impact and any future changes to the management team.
• Financial/stock-structure impact: The board’s newly approved authority to implement a reverse stock split (ratios up to 1-for-100, aggregate up to 1-for-500) could be used to consolidate shares and affect the company’s share price and listing status; any actual split would change share count and per-share metrics.
• Cash impact: The company has an immediate compensation obligation to Dr. Regan (six months at $50,000/month) and ongoing compensation commitments under Mr. Bligh’s employment terms that could affect near-term cash needs.
• Governance: Stockholders also approved the auditor and several equity issuance proposals under Nasdaq rules, which, if exercised, could dilute existing holders; shareholders should monitor future filings for implementation details.